Pharmaco - Press Releases

Date	Title	Company
02-Nov-2021	BioMed X Institute Successfully Completes Fourth Project in Oncology in Collaboration with Merck KGaA, Darmstadt, Germany	B3C newswire
02-Nov-2021	Antibiotic Research UK awards grants to fund research worth £200,000	Sciad Newswire
02-Nov-2021	SYNLAB closes the acquisition of 100 percent of Laboratorio Médico Polanco and Laboratorio Clinicos de Puebla in Mexico	SYNLAB AG
02-Nov-2021	Fresenius Medical Care AG & Co. KGaA confirms outlook for 2021 while considering the continued negative impact of COVID-19	Fresenius Medical Care AG & Co. KGaA
02-Nov-2021	Fresenius Medical Care AG & Co. KGaA transforms its operating model, entering the next phase of its 2025 growth strategy	Fresenius Medical Care AG & Co. KGaA
01-Nov-2021	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Third Quarter 2021 Financial Results on November 4, 2021	Vivoryon Therapeutics N.V.
29-Oct-2021	Polyphor shareholders approve all resolutions for the planned merger with EnBiotix at the Extraordinary General Meeting	Polyphor AG
29-Oct-2021	Thrombolytic Science Granted US Patent on Novel Clot Dissolving Therapy, Complementing Patent Protection in Europe, Japan, China, Hong Kong, Mexico & CIS	B3C newswire
28-Oct-2021	STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2021 AND RAISES FINANCIAL GUIDANCE	STRATEC SE
28-Oct-2021	Alexandre Pasini Appointed Chief Operating Officer (COO) at Celonic	B3C newswire
28-Oct-2021	Vita 34 AG: Exchange Offer PBKM - 95% Minimum Acceptance Rate Exceeded	Vita 34 AG
28-Oct-2021	Heidelberg Pharma Participates at Various Conferences	Heidelberg Pharma AG
28-Oct-2021	MagForce AG Publishes Financial Results for H1/2021 and Operative Highlights	MagForce AG
28-Oct-2021	Antibiotic Research UK’s annual lecture calls for global governments to transform funding of new antibiotic sales to prevent another health emergency	Sciad Newswire
28-Oct-2021	Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes	Zur Rose Group AG
28-Oct-2021	Straumann Group reports above 30% third-quarter revenue growth driven by continued strong patient flow	Straumann Holding AG
27-Oct-2021	Another seven million Euros for SynBiotic SE	SynBiotic SE
27-Oct-2021	Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Positive Interim Data from Its Clinical Trial of Novel Nasal Spray Sentinox in SARS-CoV-2 Infected Patients	RELIEF THERAPEUTICS Holding AG
26-Oct-2021	Evotec SE: Announces launch of public offering of American Depositary Shares	Evotec SE
26-Oct-2021	Secarna Pharmaceuticals and Denali Therapeutics expand strategic partnership for the discovery and development of novel ASO therapeutics in the field of CNS diseases	Secarna Pharmaceuticals GmbH & Co. KG